BlossomHill Therapeutics, Inc. BLSM · SEC Filings

website

Blossomhill Therapeutics, Inc. is a biopharmaceutical company. It engages in the development of smal...

Price14.46

Market Cap459.61 M

Float9.57 M

CountryUS

SectorHealthcare

ExchangeNASDAQ

Overview Filings Insights Dilution News Transcripts

Search in Documents

Open in Studio Login

TYPE

HEADLINE

FILED AT

TYPE

HEADLINE

FILED AT

TYPE

HEADLINE

FILED AT

TYPE

HEADLINE

FILED AT

Financials

TYPE

HEADLINE

FILED AT

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Sep 18, 2026

News

TYPE

HEADLINE

FILED AT

8-K

BlossomHill Therapeutics Reports Second Quarter 2026 Financial Results and Highlights Pipeline Progress

Sep 18, 2026

8-K

BlossomHill Therapeutics Presents Updated Phase 1/2 SOLARA Trial Data for BH-30643 in EGFR C797S-Positive NSCLC at IASLC 2026

Sep 15, 2026

8-K

BlossomHill Therapeutics, Inc. Completes Initial Public Offering

Aug 10, 2026

Prospectus

TYPE

HEADLINE

FILED AT

424B4

IPO | Offering amount: $150,000,000 | Shares: 9,375,000 | Price: $16.000 | Bank: J.P. Morgan

Aug 7, 2026

Registrations

TYPE

HEADLINE

FILED AT

S-8

Form S-8 - Securities to be offered to employees in employee benefit plans

Aug 10, 2026

S-1MEF

OFFERING

Aug 6, 2026

8-A12B

Form 8-A12B - Registration of securities [Section 12(b)]

Aug 4, 2026

S-1/A

OFFERING - IPO | Bank: J.P. Morgan; Leerink Partners; Guggenheim Securities; LifeSci Capital; H.C. Wainwright & Co.

Aug 3, 2026

S-1

Form S-1 - General form for registration of securities under the Securities Act of 1933

Jul 16, 2026

DRS/A

Form DRS/A - Draft Registration Statement: [Amend]

Jun 11, 2026

Proxies

TYPE

HEADLINE

FILED AT

Ownerships

TYPE

HEADLINE

FILED AT

SCHEDULE 13D

ORBIMED ADVISORS LLC (Filed by)

Aug 18, 2026

SCHEDULE 13G

Vivo Innovation Fund II Holdings, L.P. (Filed by)

Aug 17, 2026

SCHEDULE 13G

PERCEPTIVE ADVISORS LLC (Filed by)

Aug 14, 2026

SCHEDULE 13D

Cormorant Asset Management, LP (Filed by)

Aug 13, 2026

GORDON CARL L (Reporting)

Aug 12, 2026

ORBIMED ADVISORS LLC (Reporting)

Aug 12, 2026

Other

TYPE

HEADLINE

FILED AT